European shares closed in the green amid a global equity rebound after last week’s sell-off inspired by fears of an artificial intelligence (AI)...

Novo Nordisk’s Denmark-listed shares climbed more than 7%, while the stock gained close to 6% in US premarket trading after telehealth company...

Hims and Hers announced a halt in sales of their copy of the weight-loss drug, Wegovy. This decision followed talks with stakeholders. Initially, Hims...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday - two days after it announced...

Swiss drugmaker’s CEO says launch of weight loss pill has been ‘one of the most successful pharmaceutical debuts ever’

Swiss drugmaker’s CEO says launch of weight loss pill has been ‘one of the most successful pharmaceutical debuts ever’

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced...

MONDAY, Feb. 9, 2026 — Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal...

Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention ......